Microbiome interventions for children raise the ethical stakes
Briefly

Probiotics have intrigued scientists for more than a century and their potential for treating or preventing diseases has led to a growing industry, valued at $87.7 billion in 2023.
The death of a preterm baby after receiving a hospital probiotic sparked concern among scientists and regulators about the safety of probiotics, especially for vulnerable populations like infants.
Deanna Gibson emphasizes the need for caution, saying, 'Bacteria are powerful. That's why I worry so much about infants and us influencing the microbiome in ways that could have unintended consequences.'
Read at Nature
[
|
]